期刊文献+

The Relationship between Glucose Excursion and Cognitive Function in Aged Type 2 Diabetes Patients 被引量:34

The Relationship between Glucose Excursion and Cognitive Function in Aged Type 2 Diabetes Patients
在线阅读 下载PDF
导出
摘要 Objective Evidence suggests that type 2 diabetes (T2DM) is associated with an increased risk of dementia and that glucose variability is an independent risk factor for diabetic complications. This study investigated the relationship between glucose excursion and cognitive function in aged T2DM patients. Methods A total of 248 aged T2DM patients wore a continuous glucose monitoring system (CGMS) for 3 days in order to evaluate glucose excursion, including mean amplitude of glycemic excursions (MAGE) and mean of daily difference (MODD). All subjects were evaluated with a number of accepted cognitive function tests, including the mini-mental status examination (MMSE). The relationship between MAGE and MODD and performance on these cognitive tests was assessed. Results The MAGE and MMSE score were negatively correlated, likewise with the correlation between MODD and MMSE. Liner multivariate regression analysis showed that MAGE and MODD were also negatively related to MMSE independent of age, sex, glycemic control, hypertension, smoking, or coronary heart disease history. Conclusion Glucose excursion is related to cognitive function in aged T2DM patients. Elevated glucose excursion decreased the MMSE score, which reflects general cognitive function. Thus, therapy aimed at controlling glucose excursion may be beneficial for maintaining cognitive function in aged T2DM patients. Objective Evidence suggests that type 2 diabetes (T2DM) is associated with an increased risk of dementia and that glucose variability is an independent risk factor for diabetic complications. This study investigated the relationship between glucose excursion and cognitive function in aged T2DM patients. Methods A total of 248 aged T2DM patients wore a continuous glucose monitoring system (CGMS) for 3 days in order to evaluate glucose excursion, including mean amplitude of glycemic excursions (MAGE) and mean of daily difference (MODD). All subjects were evaluated with a number of accepted cognitive function tests, including the mini-mental status examination (MMSE). The relationship between MAGE and MODD and performance on these cognitive tests was assessed. Results The MAGE and MMSE score were negatively correlated, likewise with the correlation between MODD and MMSE. Liner multivariate regression analysis showed that MAGE and MODD were also negatively related to MMSE independent of age, sex, glycemic control, hypertension, smoking, or coronary heart disease history. Conclusion Glucose excursion is related to cognitive function in aged T2DM patients. Elevated glucose excursion decreased the MMSE score, which reflects general cognitive function. Thus, therapy aimed at controlling glucose excursion may be beneficial for maintaining cognitive function in aged T2DM patients.
出处 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2012年第1期1-7,共7页 生物医学与环境科学(英文版)
基金 funded by the Medical College Natural Science Foundation of Shanghai Jiaotong University (09XJ21028)
关键词 Glucose excursion Continuous glucose monitoring system Diabetes mellitus Aged Glucose excursion Continuous glucose monitoring system Diabetes mellitus Aged
  • 相关文献

参考文献26

  • 1The Diabetes Control and Complications Trial Research Group (DCCT). The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993; 329, 977-86.
  • 2UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas of insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 1998; 352,837-57.
  • 3UK Prospective Diabetes Study (UI(PDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes {UKPDS 341. Lancet. 1998; 352, 854-65.
  • 4Monnier L, Colette C. Glycemic variability: should we and can we prevent it? Diabetes care, 2008; 88, 2977-81.
  • 5Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications, 2005; 19, 198-81.
  • 6Klonoff DC. Continuous glucose monitoring roadmap for 21st century therapy. Diabetes Care, 2005; 28, 1231-9.
  • 7Hirsch JB, Armstrong D, Bergenstal RM, et al. Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM). Diabetes Technol Ther, 2008; 10, 232-44: quiz245-6.
  • 8Arvanitakis Z, Wilson RS, Bieias JL. et al. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol, 2004; 61, 661-6.
  • 9Yamada M, Kasagi F, Sasaki H, et al. Association between dementia and midlife risk factors: the Radiation Effects Research Foundation Adult Health Study. J Am Geriatr Soc, 2003; 51,43.0-14.
  • 10Leibson CL, Rocca WA, Hanson VA, etal. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol, 1997; 145, 301-8.

同被引文献190

引证文献34

二级引证文献348

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部